Lindbrook Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-203
| Closed | -$11.9K | – | 2788 |
|
|
2023
Q4 | $11.9K | Buy |
203
+5
| +3% | +$294 | ﹤0.01% | 1451 |
|
|
2023
Q3 | $8.63K | Sell |
198
-105
| -35% | -$4.57K | ﹤0.01% | 1491 |
|
|
2023
Q2 | $10.9K | Buy |
303
+80
| +36% | +$2.89K | ﹤0.01% | 1404 |
|
|
2023
Q1 | $8.29K | Buy |
223
+131
| +142% | +$4.87K | ﹤0.01% | 1573 |
|
|
2022
Q4 | $4.17K | Sell |
92
-79
| -46% | -$3.58K | ﹤0.01% | 1914 |
|
|
2022
Q3 | $12K | Buy |
171
+52
| +44% | +$3.65K | ﹤0.01% | 1261 |
|
|
2022
Q2 | $8K | Buy |
119
+113
| +1,883% | +$7.6K | ﹤0.01% | 1378 |
|
|
2022
Q1 | $0 | Sell |
6
-14
| -70% | – | ﹤0.01% | 2656 |
|
|
2021
Q4 | $3K | Buy |
20
+10
| +100% | +$1.5K | ﹤0.01% | 1719 |
|
|
2021
Q3 | $2K | Buy |
10
+7
| +233% | +$1.4K | ﹤0.01% | 1642 |
|
|
2021
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2024 |
|
|
2021
Q1 | – | Sell |
-9
| Closed | -$2K | – | 1958 |
|
|
2020
Q4 | $2K | Buy |
+9
| New | +$2K | ﹤0.01% | 1536 |
|